| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | GTPase activator activity | TBC1D3E TBC1D3 TBC1D3H TBC1D3L TBC1D3D RABGAP1 TBC1D3C TBC1D3B TBC1D3I TBC1D3G TBC1D3K TBC1D3F | 1.59e-07 | 279 | 123 | 12 | GO:0005096 |
| GeneOntologyMolecularFunction | nucleoside-triphosphatase regulator activity | TBC1D3E TBC1D3 TBC1D3H TBC1D3L TBC1D3D RABGAP1 TBC1D3C TBC1D3B TBC1D3I TBC1D3G TBC1D3K TBC1D3F | 7.06e-05 | 507 | 123 | 12 | GO:0060589 |
| GeneOntologyMolecularFunction | GTPase regulator activity | TBC1D3E TBC1D3 TBC1D3H TBC1D3L TBC1D3D RABGAP1 TBC1D3C TBC1D3B TBC1D3I TBC1D3G TBC1D3K TBC1D3F | 7.06e-05 | 507 | 123 | 12 | GO:0030695 |
| GeneOntologyMolecularFunction | extracellular matrix structural constituent | 1.66e-04 | 188 | 123 | 7 | GO:0005201 | |
| GeneOntologyMolecularFunction | enzyme activator activity | TBC1D3E TBC1D3 TBC1D3H TBC1D3L TBC1D3D RABGAP1 TBC1D3C TBC1D3B SUZ12 TBC1D3I TBC1D3G TBC1D3K TBC1D3F | 2.06e-04 | 656 | 123 | 13 | GO:0008047 |
| GeneOntologyBiologicalProcess | activation of GTPase activity | TBC1D3E TBC1D3 TBC1D3H TBC1D3L TBC1D3D TBC1D3C TBC1D3B TBC1D3I TBC1D3G TBC1D3K TBC1D3F | 6.02e-11 | 109 | 125 | 11 | GO:0090630 |
| GeneOntologyBiologicalProcess | positive regulation of GTPase activity | TBC1D3E TBC1D3 TBC1D3H TBC1D3L TBC1D3D TBC1D3C TBC1D3B TBC1D3I TBC1D3G TBC1D3K TBC1D3F | 2.87e-07 | 244 | 125 | 11 | GO:0043547 |
| GeneOntologyBiologicalProcess | regulation of GTPase activity | TBC1D3E TBC1D3 TBC1D3H TBC1D3L TBC1D3D RABGAP1 TBC1D3C TBC1D3B TBC1D3I TBC1D3G TBC1D3K TBC1D3F | 9.45e-07 | 335 | 125 | 12 | GO:0043087 |
| GeneOntologyCellularComponent | extracellular matrix | VWF LAMB1 MUC5B BCAN LRRTM1 ITGB4 MFAP4 THBS2 FCGBP HMCN2 HMCN1 SERPINB12 GPC4 ADAMTS14 MUC2 | 1.09e-05 | 656 | 127 | 15 | GO:0031012 |
| GeneOntologyCellularComponent | external encapsulating structure | VWF LAMB1 MUC5B BCAN LRRTM1 ITGB4 MFAP4 THBS2 FCGBP HMCN2 HMCN1 SERPINB12 GPC4 ADAMTS14 MUC2 | 1.13e-05 | 658 | 127 | 15 | GO:0030312 |
| GeneOntologyCellularComponent | lysosomal lumen | 3.31e-04 | 98 | 127 | 5 | GO:0043202 | |
| GeneOntologyCellularComponent | collagen-containing extracellular matrix | VWF LAMB1 BCAN ITGB4 MFAP4 THBS2 HMCN2 HMCN1 SERPINB12 GPC4 MUC2 | 3.95e-04 | 530 | 127 | 11 | GO:0062023 |
| Domain | TBC | TBC1D3E TBC1D3H TBC1D3L TBC1D3D RABGAP1 TBC1D3C TBC1D3B TBC1D3I TBC1D3G TBC1D3K TBC1D3F | 1.14e-14 | 49 | 120 | 11 | SM00164 |
| Domain | RabGAP-TBC | TBC1D3E TBC1D3H TBC1D3L TBC1D3D RABGAP1 TBC1D3C TBC1D3B TBC1D3I TBC1D3G TBC1D3K TBC1D3F | 2.93e-14 | 53 | 120 | 11 | PF00566 |
| Domain | Rab-GTPase-TBC_dom | TBC1D3E TBC1D3H TBC1D3L TBC1D3D RABGAP1 TBC1D3C TBC1D3B TBC1D3I TBC1D3G TBC1D3K TBC1D3F | 4.55e-14 | 55 | 120 | 11 | IPR000195 |
| Domain | TBC_RABGAP | TBC1D3E TBC1D3H TBC1D3L TBC1D3D RABGAP1 TBC1D3C TBC1D3B TBC1D3I TBC1D3G TBC1D3K TBC1D3F | 4.55e-14 | 55 | 120 | 11 | PS50086 |
| Domain | VWC_out | 1.09e-07 | 19 | 120 | 5 | SM00215 | |
| Domain | VWC | 1.45e-07 | 38 | 120 | 6 | SM00214 | |
| Domain | VWF_dom | 2.69e-07 | 42 | 120 | 6 | IPR001007 | |
| Domain | C8 | 7.71e-07 | 12 | 120 | 4 | PF08742 | |
| Domain | TIL | 7.71e-07 | 12 | 120 | 4 | PF01826 | |
| Domain | Unchr_dom_Cys-rich | 1.11e-06 | 13 | 120 | 4 | IPR014853 | |
| Domain | C8 | 1.11e-06 | 13 | 120 | 4 | SM00832 | |
| Domain | TIL_dom | 1.54e-06 | 14 | 120 | 4 | IPR002919 | |
| Domain | VWF_type-D | 2.78e-06 | 16 | 120 | 4 | IPR001846 | |
| Domain | VWFD | 2.78e-06 | 16 | 120 | 4 | PS51233 | |
| Domain | VWD | 2.78e-06 | 16 | 120 | 4 | SM00216 | |
| Domain | VWD | 2.78e-06 | 16 | 120 | 4 | PF00094 | |
| Domain | VWFC_1 | 3.24e-06 | 36 | 120 | 5 | PS01208 | |
| Domain | VWFC_2 | 4.27e-06 | 38 | 120 | 5 | PS50184 | |
| Domain | VWC | 2.95e-05 | 28 | 120 | 4 | PF00093 | |
| Domain | CSTF2_hinge | 4.09e-05 | 2 | 120 | 2 | PF14327 | |
| Domain | CSTF_C | 4.09e-05 | 2 | 120 | 2 | PF14304 | |
| Domain | CSTF2_hinge | 4.09e-05 | 2 | 120 | 2 | IPR025742 | |
| Domain | CSTF_C | 4.09e-05 | 2 | 120 | 2 | IPR026896 | |
| Domain | VWFA | 1.85e-04 | 82 | 120 | 5 | PS50234 | |
| Domain | CTCK_1 | 1.97e-04 | 18 | 120 | 3 | PS01185 | |
| Domain | VWA | 2.07e-04 | 84 | 120 | 5 | SM00327 | |
| Domain | EGF-like_dom | 2.07e-04 | 249 | 120 | 8 | IPR000742 | |
| Domain | EGF_CA | 2.32e-04 | 86 | 120 | 5 | PF07645 | |
| Domain | G2F | 2.44e-04 | 4 | 120 | 2 | PF07474 | |
| Domain | NIDOGEN_G2 | 2.44e-04 | 4 | 120 | 2 | PS50993 | |
| Domain | GFP | 2.44e-04 | 4 | 120 | 2 | IPR009017 | |
| Domain | G2_nidogen/fibulin_G2F | 2.44e-04 | 4 | 120 | 2 | IPR006605 | |
| Domain | EGF_1 | 2.44e-04 | 255 | 120 | 8 | PS00022 | |
| Domain | EGF-like_CS | 2.85e-04 | 261 | 120 | 8 | IPR013032 | |
| Domain | EGF_2 | 3.16e-04 | 265 | 120 | 8 | PS01186 | |
| Domain | Sushi | 3.46e-04 | 52 | 120 | 4 | PF00084 | |
| Domain | CT | 3.64e-04 | 22 | 120 | 3 | SM00041 | |
| Domain | CCP | 4.00e-04 | 54 | 120 | 4 | SM00032 | |
| Domain | DMAP_binding | 4.04e-04 | 5 | 120 | 2 | PF06464 | |
| Domain | VWF_A | 4.45e-04 | 99 | 120 | 5 | IPR002035 | |
| Domain | SUSHI | 4.60e-04 | 56 | 120 | 4 | PS50923 | |
| Domain | Sushi_SCR_CCP_dom | 4.92e-04 | 57 | 120 | 4 | IPR000436 | |
| Domain | Cys_knot_C | 5.37e-04 | 25 | 120 | 3 | IPR006207 | |
| Domain | CTCK_2 | 5.37e-04 | 25 | 120 | 3 | PS01225 | |
| Domain | DMAP1-bd | 6.04e-04 | 6 | 120 | 2 | IPR010506 | |
| Domain | WxxW_domain | 6.04e-04 | 6 | 120 | 2 | IPR025155 | |
| Domain | Mucin2_WxxW | 6.04e-04 | 6 | 120 | 2 | PF13330 | |
| Domain | DMAP_binding | 6.04e-04 | 6 | 120 | 2 | SM01137 | |
| Domain | EGF | 8.15e-04 | 235 | 120 | 7 | SM00181 | |
| Domain | 14_3_3 | 8.42e-04 | 7 | 120 | 2 | SM00101 | |
| Domain | 1433_1 | 8.42e-04 | 7 | 120 | 2 | PS00796 | |
| Domain | 1433_2 | 8.42e-04 | 7 | 120 | 2 | PS00797 | |
| Domain | 14-3-3_domain | 8.42e-04 | 7 | 120 | 2 | IPR023410 | |
| Domain | 14-3-3_CS | 8.42e-04 | 7 | 120 | 2 | IPR023409 | |
| Domain | 14-3-3 | 8.42e-04 | 7 | 120 | 2 | PF00244 | |
| Domain | 14-3-3 | 1.12e-03 | 8 | 120 | 2 | IPR000308 | |
| Domain | EGF_CA | 1.15e-03 | 122 | 120 | 5 | SM00179 | |
| Domain | EGF-like_Ca-bd_dom | 1.23e-03 | 124 | 120 | 5 | IPR001881 | |
| Domain | - | 1.32e-03 | 74 | 120 | 4 | 3.40.50.410 | |
| Domain | - | BRIP1 SAMD9 SMC1A CHD1 HNRNPUL1 DNAH14 EFTUD2 RND3 MTIF2 GNAZ CNP MOV10 | 3.09e-03 | 746 | 120 | 12 | 3.40.50.300 |
| Domain | Growth_fac_rcpt_ | 3.36e-03 | 156 | 120 | 5 | IPR009030 | |
| Domain | EGF_Ca-bd_CS | 3.55e-03 | 97 | 120 | 4 | IPR018097 | |
| Domain | EGF_CA | 3.82e-03 | 99 | 120 | 4 | PS01187 | |
| Domain | ASX_HYDROXYL | 3.95e-03 | 100 | 120 | 4 | PS00010 | |
| Domain | EGF_3 | 4.13e-03 | 235 | 120 | 6 | PS50026 | |
| Domain | EGF-type_Asp/Asn_hydroxyl_site | 4.87e-03 | 106 | 120 | 4 | IPR000152 | |
| Domain | EFTu-like_2 | 5.86e-03 | 18 | 120 | 2 | IPR004161 | |
| Domain | GTP_EFTU_D2 | 5.86e-03 | 18 | 120 | 2 | PF03144 | |
| Domain | G_TR_2 | 5.86e-03 | 18 | 120 | 2 | PS51722 | |
| Pathway | WP_17Q12_COPY_NUMBER_VARIATION_SYNDROME | TBC1D3E TBC1D3 TBC1D3H TBC1D3L TBC1D3C TBC1D3B TBC1D3I TBC1D3G TBC1D3K | 2.95e-08 | 99 | 99 | 9 | M46448 |
| Pathway | REACTOME_DISEASES_OF_GLYCOSYLATION | 6.52e-05 | 143 | 99 | 7 | M27275 | |
| Pathway | REACTOME_DISEASES_ASSOCIATED_WITH_O_GLYCOSYLATION_OF_PROTEINS | 1.13e-04 | 68 | 99 | 5 | M27303 | |
| Pubmed | TBC1D3, a hominoid oncoprotein, is encoded by a cluster of paralogues located on chromosome 17q12. | TBC1D3E TBC1D3 TBC1D3H TBC1D3L TBC1D3D TBC1D3C TBC1D3B TBC1D3I TBC1D3G TBC1D3K TBC1D3F | 1.08e-27 | 11 | 128 | 11 | 16863688 |
| Pubmed | DNA sequence of human chromosome 17 and analysis of rearrangement in the human lineage. | 1.14e-08 | 74 | 128 | 7 | 16625196 | |
| Pubmed | Immunoglobulin genes of different subgroups are interdigitated within the VK locus. | 4.87e-08 | 3 | 128 | 3 | 6440122 | |
| Pubmed | PRC17, a novel oncogene encoding a Rab GTPase-activating protein, is amplified in prostate cancer. | 1.94e-07 | 4 | 128 | 3 | 12359748 | |
| Pubmed | 1.94e-07 | 4 | 128 | 3 | 8406013 | ||
| Pubmed | 4.01e-07 | 17 | 128 | 4 | 8223863 | ||
| Pubmed | 4.84e-07 | 5 | 128 | 3 | 12604796 | ||
| Pubmed | 4.84e-07 | 5 | 128 | 3 | 8471161 | ||
| Pubmed | VWF FARSB GRIA1 BCAN LRRTM1 IGLV7-46 IGLV7-43 YWHAH SLC2A1 DIP2A FASN UBE2O SF3B3 YWHAQ GNAZ ABHD12 TRAPPC9 CNP CACNA2D3 | 1.29e-06 | 1431 | 128 | 19 | 37142655 | |
| Pubmed | 14-3-3 proteins interact with a hybrid prenyl-phosphorylation motif to inhibit G proteins. | 2.69e-06 | 8 | 128 | 3 | 23622247 | |
| Pubmed | 3.28e-06 | 109 | 128 | 6 | 12226669 | ||
| Pubmed | Irisin Mediates Effects on Bone and Fat via αV Integrin Receptors. | ACP2 LAMB1 PLBD2 SLC2A1 EFTUD2 TMED3 THBS2 FASN SF3B3 GUSB MTIF2 TAX1BP1 C1R YWHAQ ADAMTS14 GNAZ TRAPPC9 NOTCH2 | 6.44e-06 | 1451 | 128 | 18 | 30550785 |
| Pubmed | 7.86e-06 | 11 | 128 | 3 | 25849387 | ||
| Pubmed | 8.91e-06 | 197 | 128 | 7 | 31620119 | ||
| Pubmed | A family of splice variants of CstF-64 expressed in vertebrate nervous systems. | 1.34e-05 | 2 | 128 | 2 | 19284619 | |
| Pubmed | Fatty acid synthase modulates intestinal barrier function through palmitoylation of mucin 2. | 1.34e-05 | 2 | 128 | 2 | 22341463 | |
| Pubmed | Recognition of GU-rich polyadenylation regulatory elements by human CstF-64 protein. | 1.34e-05 | 2 | 128 | 2 | 12773396 | |
| Pubmed | 1.34e-05 | 2 | 128 | 2 | 17029590 | ||
| Pubmed | 1.34e-05 | 2 | 128 | 2 | 12137943 | ||
| Pubmed | 1.34e-05 | 2 | 128 | 2 | 34126068 | ||
| Pubmed | Overlapping and distinct functions of CstF64 and CstF64τ in mammalian mRNA 3' processing. | 1.34e-05 | 2 | 128 | 2 | 24149845 | |
| Pubmed | Sortilin is a major protein component of Glut4-containing vesicles. | 1.34e-05 | 2 | 128 | 2 | 9305862 | |
| Pubmed | 1.34e-05 | 2 | 128 | 2 | 19432394 | ||
| Pubmed | 1.34e-05 | 2 | 128 | 2 | 9407109 | ||
| Pubmed | 1.34e-05 | 2 | 128 | 2 | 14681198 | ||
| Pubmed | Mammalian hemicentin 1 is assembled into tracks in the extracellular matrix of multiple tissues. | 1.34e-05 | 2 | 128 | 2 | 32035013 | |
| Pubmed | 1.34e-05 | 2 | 128 | 2 | 30920297 | ||
| Pubmed | 1.34e-05 | 2 | 128 | 2 | 17015822 | ||
| Pubmed | 1.34e-05 | 2 | 128 | 2 | 16207706 | ||
| Pubmed | [Interleukin-1beta induces MUC2/MUC5B gene expression in human nasal epithelial cells]. | 1.34e-05 | 2 | 128 | 2 | 20873538 | |
| Pubmed | 1.44e-05 | 40 | 128 | 4 | 36843585 | ||
| Pubmed | 1.72e-05 | 14 | 128 | 3 | 12919677 | ||
| Pubmed | 2.76e-05 | 47 | 128 | 4 | 814163 | ||
| Pubmed | 3.22e-05 | 98 | 128 | 5 | 19554387 | ||
| Pubmed | 3.75e-05 | 167 | 128 | 6 | 22159717 | ||
| Pubmed | The contribution of de novo coding mutations to autism spectrum disorder. | 3.82e-05 | 18 | 128 | 3 | 25363768 | |
| Pubmed | FARSB HNRNPUL1 YWHAH EFTUD2 FASN SF3B3 SERPINB12 YWHAQ CNP MOV10 | 3.92e-05 | 551 | 128 | 10 | 34728620 | |
| Pubmed | 3.97e-05 | 340 | 128 | 8 | 24332808 | ||
| Pubmed | 4.02e-05 | 3 | 128 | 2 | 12388743 | ||
| Pubmed | Specific V gene usage in anti-phosphorylcholine IgE antibodies. | 4.02e-05 | 3 | 128 | 2 | 8247027 | |
| Pubmed | 4.02e-05 | 3 | 128 | 2 | 10562316 | ||
| Pubmed | 4.02e-05 | 3 | 128 | 2 | 6265582 | ||
| Pubmed | Genetic polymorphism of lambda 1 and lambda 3 immunoglobulin light chains in the Mus subgenus. | 4.02e-05 | 3 | 128 | 2 | 6189723 | |
| Pubmed | 4.02e-05 | 3 | 128 | 2 | 403522 | ||
| Pubmed | Nucleotide sequence of a chromosomal rearranged lambda 2 immunoglobulin gene of mouse. | 4.02e-05 | 3 | 128 | 2 | 6287422 | |
| Pubmed | Amino acid sequence of the light chain of a mouse myeloma protein (MOPC-315). | 4.02e-05 | 3 | 128 | 2 | 4760498 | |
| Pubmed | Sequences of 12 monoclonal anti-dinitrophenyl spin-label antibodies for NMR studies. | 4.02e-05 | 3 | 128 | 2 | 3375235 | |
| Pubmed | Diversity of human copy number variation and multicopy genes. | 4.02e-05 | 3 | 128 | 2 | 21030649 | |
| Pubmed | Functional, molecular and structural characterisation of five anti-Brucella LPS mAb. | 4.02e-05 | 3 | 128 | 2 | 15128040 | |
| Pubmed | 4.02e-05 | 3 | 128 | 2 | 4516208 | ||
| Pubmed | 4.02e-05 | 3 | 128 | 2 | 8318454 | ||
| Pubmed | 4.02e-05 | 3 | 128 | 2 | 17236128 | ||
| Pubmed | 4.02e-05 | 3 | 128 | 2 | 10427979 | ||
| Pubmed | Astrocyte glypicans 4 and 6 promote formation of excitatory synapses via GluA1 AMPA receptors. | 4.02e-05 | 3 | 128 | 2 | 22722203 | |
| Pubmed | Sequences of mouse immunoglobulin light chain genes before and after somatic changes. | 4.02e-05 | 3 | 128 | 2 | 103630 | |
| Pubmed | 4.02e-05 | 3 | 128 | 2 | 11920561 | ||
| Pubmed | 4.02e-05 | 3 | 128 | 2 | 7643860 | ||
| Pubmed | 4.02e-05 | 3 | 128 | 2 | 14754898 | ||
| Pubmed | Mouse immunoglobulin gene rearrangements. The sequence of a nonexpressed lambda 3-chain gene. | 4.02e-05 | 3 | 128 | 2 | 2987352 | |
| Pubmed | 4.02e-05 | 3 | 128 | 2 | 8232332 | ||
| Pubmed | A linkage map of the mouse immunoglobulin lambda light chain locus. | 4.02e-05 | 3 | 128 | 2 | 2494106 | |
| Pubmed | Comparative sequence and immunochemical analyses of murine monoclonal anti-morphine antibodies. | 4.02e-05 | 3 | 128 | 2 | 2555519 | |
| Pubmed | 4.02e-05 | 3 | 128 | 2 | 9032408 | ||
| Pubmed | 4.02e-05 | 3 | 128 | 2 | 418802 | ||
| Pubmed | Physical linkage of the constant region genes for immunoglobulins lambda I and lambda III. | 4.02e-05 | 3 | 128 | 2 | 6267606 | |
| Pubmed | A secreted protein promotes cleavage furrow maturation during cytokinesis. | 4.02e-05 | 3 | 128 | 2 | 21215633 | |
| Pubmed | 4.02e-05 | 3 | 128 | 2 | 19718741 | ||
| Pubmed | Specificity change of antibody to (4-hydroxy-3-nitrophenyl)acetyl haptens by somatic hypermutation. | 4.02e-05 | 3 | 128 | 2 | 3129412 | |
| Pubmed | High frequency expression of S107 VH genes by peritoneal B cells of B10.H-2aH-4bP/WTS mice. | 4.02e-05 | 3 | 128 | 2 | 2117034 | |
| Pubmed | Somatic variants of murine immunoglobulin lambda light chains. | 4.02e-05 | 3 | 128 | 2 | 6283385 | |
| Pubmed | Sequence of a mouse germ-line gene for a variable region of an immunoglobulin light chain. | 4.02e-05 | 3 | 128 | 2 | 418414 | |
| Pubmed | Dual expression of lambda genes in the MOPC-315 plasmacytoma. | 4.02e-05 | 3 | 128 | 2 | 6259534 | |
| Pubmed | 4.02e-05 | 3 | 128 | 2 | 1918968 | ||
| Pubmed | 4.02e-05 | 3 | 128 | 2 | 19553522 | ||
| Pubmed | Lambda light chain constant and variable gene complements in wild-derived inbred mouse strains. | 4.02e-05 | 3 | 128 | 2 | 3924628 | |
| Pubmed | 4.02e-05 | 3 | 128 | 2 | 98276 | ||
| Pubmed | Amino acid sequences of two mouse immunoglobulin lambda chains. | 4.02e-05 | 3 | 128 | 2 | 5276767 | |
| Pubmed | Structural evidence for the functional importance of the heme domain mobility in flavocytochrome b2. | 4.02e-05 | 3 | 128 | 2 | 20546754 | |
| Pubmed | 4.02e-05 | 3 | 128 | 2 | 26057585 | ||
| Pubmed | 4.02e-05 | 3 | 128 | 2 | 8647454 | ||
| Pubmed | Morphology, GluR1 and GRIP-C localization differ in octopus cells of C57BL6 and B6Cast mice. | 4.02e-05 | 3 | 128 | 2 | 12204345 | |
| Pubmed | 4.02e-05 | 3 | 128 | 2 | 6202790 | ||
| Pubmed | 4.02e-05 | 3 | 128 | 2 | 17015624 | ||
| Pubmed | 4.02e-05 | 3 | 128 | 2 | 1378065 | ||
| Pubmed | 4.02e-05 | 3 | 128 | 2 | 8805642 | ||
| Pubmed | Mutational analysis of avidity and fine specificity of anti-levan antibodies. | 4.02e-05 | 3 | 128 | 2 | 10586066 | |
| Pubmed | 4.02e-05 | 3 | 128 | 2 | 2453579 | ||
| Pubmed | Clonal recruitment and somatic mutation in the generation of immunological memory to the hapten NP. | 4.02e-05 | 3 | 128 | 2 | 2430792 | |
| Pubmed | A new V gene expressed in lambda-2 light chains of the mouse. | 4.02e-05 | 3 | 128 | 2 | 3034625 | |
| Pubmed | 4.02e-05 | 3 | 128 | 2 | 8190131 | ||
| Pubmed | Molecular and biochemical analyses of combining sites of monoclonal anti-morphine antibodies. | 4.02e-05 | 3 | 128 | 2 | 8417377 | |
| Pubmed | Restricted Ig variable region gene expression among Ly-1+ B cell lymphomas. | 4.02e-05 | 3 | 128 | 2 | 3139765 | |
| Pubmed | In-depth proteomic analyses of exosomes isolated from expressed prostatic secretions in urine. | EPHX2 ACP2 SRI CD55 MUC5B PLBD2 FASN FCGBP HMCN1 GUSB C1R IGKV3D-11 CNP SH3BGRL3 | 4.20e-05 | 1070 | 128 | 14 | 23533145 |
| Pubmed | Proteome-wide identification of HSP70/HSC70 chaperone clients in human cells. | BCAS2 MUC5B RABGAP1 HNRNPUL1 YWHAH PLBD2 SLC2A1 EFTUD2 FASN UBE2O HEATR6 FCGBP SF3B3 SERPINB12 YWHAQ CNP | 4.42e-05 | 1367 | 128 | 16 | 32687490 |
| Pubmed | Harnessing host enhancers of SARS-CoV-2 entry as novel targets for antiviral therapy. | 5.16e-05 | 55 | 128 | 4 | 38945485 | |
| Pubmed | CHK2 kinase promotes pre-mRNA splicing via phosphorylating CDK11(p110). | 5.16e-05 | 55 | 128 | 4 | 23178491 | |
| Pubmed | MKRN2 Physically Interacts with GLE1 to Regulate mRNA Export and Zebrafish Retinal Development. | 5.70e-05 | 358 | 128 | 8 | 32460013 | |
| Pubmed | Targeting USP10 induces degradation of oncogenic ANLN in esophageal squamous cell carcinoma. | SAMD9 BCAS2 SMC1A FARSB HNRNPUL1 ITGB4 YWHAH SLC2A1 EFTUD2 FASN SF3B3 SERPINB12 YWHAQ CNP MOV10 | 6.26e-05 | 1257 | 128 | 15 | 36526897 |
| Pubmed | 6.32e-05 | 469 | 128 | 9 | 37314180 | ||
| Pubmed | A Human Tyrosine Phosphatase Interactome Mapped by Proteomic Profiling. | SMC1A DUSP4 NUP88 LAMB1 FARSB CHD1 PTPRU YWHAH FASN UBE2O YWHAQ ABHD12 CNP | 6.56e-05 | 974 | 128 | 13 | 28675297 |
| Interaction | NHS interactions | 9.60e-06 | 48 | 120 | 5 | int:NHS | |
| Interaction | SIRPD interactions | 1.25e-05 | 86 | 120 | 6 | int:SIRPD | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr17q12 | TBC1D3E TBC1D3 TBC1D3H TBC1D3L TBC1D3D TBC1D3C TBC1D3B TBC1D3I TBC1D3G TBC1D3K TBC1D3F | 5.09e-13 | 149 | 128 | 11 | chr17q12 |
| Cytoband | 17q12 | 9.03e-06 | 99 | 128 | 5 | 17q12 | |
| Cytoband | 2p12 | 2.03e-05 | 117 | 128 | 5 | 2p12 | |
| GeneFamily | Hyalectan proteoglycans|V-set domain containing|Sushi domain containing|C-type lectin domain containing | 1.12e-04 | 57 | 79 | 4 | 1179 | |
| GeneFamily | LIM zinc finger domain containing|LIM domain containing | 1.12e-04 | 4 | 79 | 2 | 1163 | |
| GeneFamily | 14-3-3 phospho-serine/phospho-threonine binding proteins | 3.90e-04 | 7 | 79 | 2 | 1053 | |
| GeneFamily | Immunoglobulin kappa locus at 2p11.2 | 4.78e-04 | 83 | 79 | 4 | 351 | |
| GeneFamily | Fibulins | 5.19e-04 | 8 | 79 | 2 | 556 | |
| GeneFamily | Ring finger proteins|Fanconi anemia complementation groups|Protein phosphatase 1 regulatory subunits|BRCA1 A complex|BRCA1 B complex|BRCA1 C complex | 3.40e-03 | 20 | 79 | 2 | 548 | |
| GeneFamily | CD molecules|Mucins | 3.75e-03 | 21 | 79 | 2 | 648 | |
| GeneFamily | Blood group antigens|CD molecules|I-set domain containing|Immunoglobulin like domain containing | 5.42e-03 | 161 | 79 | 4 | 593 | |
| GeneFamily | Calcium voltage-gated channel subunits | 5.72e-03 | 26 | 79 | 2 | 253 | |
| Coexpression | BOQUEST_STEM_CELL_UP | 3.53e-05 | 261 | 124 | 8 | M1834 | |
| Coexpression | NABA_ECM_GLYCOPROTEINS | 3.59e-05 | 191 | 124 | 7 | MM17059 | |
| Coexpression | NABA_ECM_GLYCOPROTEINS | 4.23e-05 | 196 | 124 | 7 | M3008 | |
| Coexpression | NABA_CORE_MATRISOME | 4.49e-05 | 270 | 124 | 8 | MM17057 | |
| Coexpression | GSE6674_ANTI_IGM_VS_PL2_3_STIM_BCELL_DN | 4.65e-05 | 199 | 124 | 7 | M6932 | |
| Coexpression | GSE17721_LPS_VS_GARDIQUIMOD_24H_BMDC_DN | 4.80e-05 | 200 | 124 | 7 | M4066 | |
| Coexpression | NABA_CORE_MATRISOME | 5.11e-05 | 275 | 124 | 8 | M5884 | |
| Coexpression | GHO_ATF5_TARGETS_DN | 5.53e-05 | 16 | 124 | 3 | M11457 | |
| Coexpression | GSE10147_IL3_VS_IL3_AND_HIVP17_STIM_PDC_DN | 6.50e-05 | 144 | 124 | 6 | M345 | |
| CoexpressionAtlas | Mesoderm Day 15_vs_Mesoderm Day 30-Confounder_removed-fold2.0_adjp0.05 | TBC1D3 TBC1D3H TBC1D3L TBC1D3D GALNT12 TBC1D3C TBC1D3B TBC1D3G TBC1D3K TBC1D3F | 1.23e-10 | 90 | 124 | 10 | PCBC_ratio_MESO-15_vs_MESO-30_cfr-2X-p05 |
| CoexpressionAtlas | Mesoderm Day 5-reprogram_OSKM-L_vs_Mesoderm Day 5-reprogram_NA-Confounder_removed-fold2.0_adjp0.05 | TBC1D3 TBC1D3H TBC1D3L CRIM1 TBC1D3D ACP2 TBC1D3C TBC1D3B SLC2A1 MFAP4 TBC1D3G TBC1D3K TBC1D3F | 1.07e-08 | 281 | 124 | 13 | PCBC_ratio_MESO-5_from-OSKM-L_vs_MESO-5_from-ESC_cfr-2X-p05 |
| CoexpressionAtlas | Mesoderm Day 5-method_mRNA_vs_Mesoderm Day 5-method_NA-Confounder_removed-fold2.0_adjp0.05 | TBC1D3 TBC1D3H TBC1D3L CRIM1 TBC1D3D ACP2 TBC1D3C TBC1D3B SLC2A1 MFAP4 TBC1D3G TBC1D3K TBC1D3F | 1.07e-08 | 281 | 124 | 13 | PCBC_ratio_MESO-5_from-mRNA_vs_MESO-5_from-ESC_cfr-2X-p05 |
| CoexpressionAtlas | DE cord blood_vs_DE blastocyst-Confounder_removed-fold2.0_adjp0.05 | VWF TBC1D3 TBC1D3H TBC1D3L TBC1D3D TBC1D3C TBC1D3B MFAP4 GNAZ TBC1D3G TBC1D3K TBC1D3F | 1.89e-08 | 242 | 124 | 12 | PCBC_ratio_DE cord blood_vs_DE blastocyst_cfr-2X-p05 |
| CoexpressionAtlas | Endoderm Differentiated Cells-method_mRNA_vs_Endoderm Differentiated Cells-method_NA-Confounder_removed-fold2.0_adjp0.05 | VWF TBC1D3 TBC1D3H TBC1D3L TBC1D3D TBC1D3C TBC1D3B MFAP4 TBC1D3G TBC1D3K TBC1D3F | 5.02e-08 | 213 | 124 | 11 | PCBC_ratio_DE_from-mRNA_vs_DE_from-ESC_cfr-2X-p05 |
| CoexpressionAtlas | Endoderm Differentiated Cells-reprogram_OSKM-L_vs_Endoderm Differentiated Cells-reprogram_NA-Confounder_removed-fold2.0_adjp0.05 | VWF TBC1D3 TBC1D3H TBC1D3L TBC1D3D TBC1D3C TBC1D3B MFAP4 TBC1D3G TBC1D3K TBC1D3F | 5.02e-08 | 213 | 124 | 11 | PCBC_ratio_DE_from-OSKM-L_vs_DE_from-ESC_cfr-2X-p05 |
| CoexpressionAtlas | Mesoderm Day 5_vs_Endoderm Differentiated Cells-Confounder_removed-fold2.0_adjp0.05 | VWF TBC1D3 TBC1D3H TBC1D3L TBC1D3D DUSP4 LAMB1 TBC1D3C TBC1D3B TBC1D3G TBC1D3K TBC1D3F | 3.94e-07 | 320 | 124 | 12 | PCBC_ratio_MESO-5_vs_DE_cfr-2X-p05 |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Mandibular Arch_top-relative-expression-ranked_1000_k-means-cluster#4 | 2.59e-05 | 203 | 124 | 8 | Facebase_RNAseq_e9.5_Mandibular Arch_1000_K4 | |
| CoexpressionAtlas | Ectoderm Differentiated Cells_vs_Endoderm Differentiated Cells-Confounder_removed-fold2.0_adjp0.05 | EPHX2 TBC1D3 TBC1D3H DET1 TBC1D3L TBC1D3D ARRDC4 GAS1 LAMB1 KDM6B TBC1D3C TBC1D3B BCO1 TBC1D3G NOTCH2 MOV10 TBC1D3K TBC1D3F | 5.25e-05 | 1075 | 124 | 18 | PCBC_ratio_ECTO_vs_DE_cfr-2X-p05 |
| CoexpressionAtlas | Ectoderm Differentiated Cells_vs_Pluripotent Stem Cells-Confounder_removed-fold2.0_adjp0.05 | EPHX2 TBC1D3 TBC1D3H DET1 TBC1D3L TBC1D3D ARRDC4 DUSP4 GAS1 LAMB1 KDM6B TBC1D3C TBC1D3B BCO1 DIP2A GNAZ TBC1D3G NOTCH2 MOV10 TBC1D3K TBC1D3F | 1.12e-04 | 1466 | 124 | 21 | PCBC_ratio_ECTO_vs_SC_cfr-2X-p05 |
| CoexpressionAtlas | dev gonad_e13.5_M_InterstitFLeydig_MafB_top-relative-expression-ranked_1000 | BRIP1 PANK3 POLA1 NTAQ1 CD55 LAMB1 RND3 MFAP4 HMCN1 NRK ETNK2 GPC4 ALDH3B2 NOTCH2 | 1.71e-04 | 773 | 124 | 14 | gudmap_dev gonad_e13.5_M_InterstitFLeydig_MafB_1000 |
| ToppCell | COVID-19-lung-Fibroblast|COVID-19 / Disease (COVID-19 only), tissue and cell type | 6.26e-09 | 198 | 128 | 9 | 3ec01a55ade5e1627258cc3cfebb2c3207a4cb43 | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-Diff_MatrixFB|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.77e-08 | 189 | 128 | 8 | a153b83314cf52808f685296cff8c95af3f4983d | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Matrix_Fibroblast|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 8.77e-08 | 192 | 128 | 8 | dcd924d6eb67d33ee9f5d3e8ab6e1d4283d6b708 | |
| ToppCell | 5'-Adult-LargeIntestine|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 9.89e-08 | 195 | 128 | 8 | 600174e35574fe7c44dd923adcf43686e7b01e39 | |
| ToppCell | 5'-Adult-Distal_Rectal-Epithelial-goblet-BEST2+_Goblet_cell|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 7.60e-07 | 175 | 128 | 7 | 019ea30ac55748463d7917abf3d3f0e804189bfd | |
| ToppCell | 5'-Adult-Distal_Rectal-Epithelial-goblet|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 8.52e-07 | 178 | 128 | 7 | 9099b47e0756d6a1b7ba1c6aa7b47c5425f649e0 | |
| ToppCell | 5'-Airway_Nasal-Mesenchymal-Fibroblastic|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 9.18e-07 | 180 | 128 | 7 | 935c091bbcd6d10b81dc4731779e5bd98205c99f | |
| ToppCell | 5'-Airway_Nasal-Mesenchymal|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 9.18e-07 | 180 | 128 | 7 | 3dd384b7f3d9582b8fec9fe05100e466e6218b76 | |
| ToppCell | tumor_Lymph_Node_/_Brain-Myeloid_cells-Alveolar_Mac|Myeloid_cells / Location, Cell class and cell subclass | 9.88e-07 | 182 | 128 | 7 | a035d45fd512bee8dac38eb387dbf39f5a8a1fed | |
| ToppCell | 5'-Airway_Nasal-Mesenchymal-Fibroblastic-fibroblastic_type_2|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.03e-06 | 183 | 128 | 7 | 803376f5260de83c48d4f7301278d078a32b3e6e | |
| ToppCell | 5'-Airway_Nasal-Mesenchymal-Fibroblastic-fibroblastic_type_2-Peribronchial_fibroblasts-Peribronchial_fibroblasts_L.2.1.3.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.03e-06 | 183 | 128 | 7 | 6d98973098c6d20c5305bce6a83a549a7d8dbfba | |
| ToppCell | 5'-Airway_Nasal-Mesenchymal-Fibroblastic-fibroblastic_type_2-Peribronchial_fibroblasts|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.03e-06 | 183 | 128 | 7 | cc7f5a17b40e8d901885174922e5fa8877643071 | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.14e-06 | 186 | 128 | 7 | f0c8de4f6ae9047b9108a47a2af8c5f42bc103b0 | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Degenerative_Descending_Thin_Limb_Cell_Type_3|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.18e-06 | 187 | 128 | 7 | c31130fc2f9f882944b2ba366a034a03f051c4b9 | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Matrix_Fibroblast-Diff_MatrixFB|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.27e-06 | 189 | 128 | 7 | e9d5e858e320c6e9913c1ea6a54967d21eda605f | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.36e-06 | 191 | 128 | 7 | b13229bb7f3713a392271aaf5dbae3edd1b9fe5a | |
| ToppCell | BAL-Severe-Myeloid-TRAM-TRAM3|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.36e-06 | 191 | 128 | 7 | 2b10a73c5d80e83d67a7121fb004a1aa86a537ef | |
| ToppCell | BAL-Severe-Myeloid-TRAM-TRAM3-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 1.36e-06 | 191 | 128 | 7 | 02e1ae144da7274171e055356d10e8d175c5347f | |
| ToppCell | Severe_COVID-19-Myeloid-TRAM3|Severe_COVID-19 / Disease group,lineage and cell class (2021.01.30) | 1.36e-06 | 191 | 128 | 7 | 05867b96199a46a415848409130697c810d18937 | |
| ToppCell | BAL-Severe-Myeloid-TRAM|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.36e-06 | 191 | 128 | 7 | 4c4f50a502e3f6768a89df686fa2830b83b8b33f | |
| ToppCell | BAL-Severe-Myeloid-TRAM|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.36e-06 | 191 | 128 | 7 | de7c88bb46f794291025ef121a89fcd94dea4ffe | |
| ToppCell | BAL-Severe-Myeloid-TRAM-TRAM3|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.41e-06 | 192 | 128 | 7 | 34505a13b8a47c9286c560122fa7861b9c331a08 | |
| ToppCell | BAL-Severe-Myeloid-TRAM-TRAM3-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.41e-06 | 192 | 128 | 7 | 57c1410ebf90c230993e065eb78385daa3360960 | |
| ToppCell | LPS_only-Stromal_mesenchymal|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.41e-06 | 192 | 128 | 7 | 162d8b5858d150ecbbd1c9bf2b19c6c9cd50a158 | |
| ToppCell | LPS_only-Stromal_mesenchymal-Matrix_Fibroblast|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.41e-06 | 192 | 128 | 7 | ee085e04d5dcfb657522484ed20b8c1ddeccfe0c | |
| ToppCell | nucseq-Mesenchymal-Fibroblastic|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.62e-06 | 196 | 128 | 7 | 7d8505dac15fa59935ccf592afc54b04c4c6554f | |
| ToppCell | nucseq-Mesenchymal|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.73e-06 | 198 | 128 | 7 | 8f52243ca8b9ba68a75ae411506a3a6de258eb97 | |
| ToppCell | 3'-GW_trimst-1-SmallIntestine-Mesenchymal-fibroblastic-Stromal_3_(KCNN3+)|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.79e-06 | 199 | 128 | 7 | eeb7d370d4dfacf705306c72ccc4919ddefacff1 | |
| ToppCell | cellseq-Mesenchymal-Fibroblastic|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.85e-06 | 200 | 128 | 7 | 8978867bf69c830b1e48cac2ad6b512dbe60f149 | |
| ToppCell | Bronchus_Control_(B.)-Stromal-TX-Fibroblasts-4|Bronchus_Control_(B.) / Sample group, Lineage and Cell type | 1.85e-06 | 200 | 128 | 7 | 54b18c92daaa3b3368c0c46134b0c27e10c8dbb0 | |
| ToppCell | cellseq2-Mesenchymal-Fibroblastic-Fibroblastic_1-AF2|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.85e-06 | 200 | 128 | 7 | 44317fbf4d1480a37b50ab2777bf1a3e4fc0c05f | |
| ToppCell | Parenchymal-10x3prime_v2-Stromal-Fibroblastic-Fibro_myofibroblast|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 1.85e-06 | 200 | 128 | 7 | 251fd2923f108cd2086961d897244b392c32ad54 | |
| ToppCell | cellseq2-Mesenchymal-Fibroblastic|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.85e-06 | 200 | 128 | 7 | 1c10597edd532bf172ca09870a937d35e2585081 | |
| ToppCell | cellseq2-Mesenchymal-Fibroblastic-Fibroblastic_1|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.85e-06 | 200 | 128 | 7 | 440dda48b09c6a8581b7ca634b0d67f1ecacf65e | |
| ToppCell | facs-Heart-RA-18m-Endothelial-endothelial_cell_of_endocardium|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.23e-06 | 168 | 128 | 6 | 06dc5b2d356d3a9454b10bba6f3b9ead2a0a7d46 | |
| ToppCell | facs-Heart-RA-18m-Endothelial-endocardial_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.23e-06 | 168 | 128 | 6 | 1002f058a340763e3d8de0bd1f0547a903526ec6 | |
| ToppCell | facs-Heart-LV-18m-Mesenchymal|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.54e-06 | 169 | 128 | 6 | 849a8f8509c58d65462a09c84d58b6ecdc8934f5 | |
| ToppCell | (07)_Ionocytes-(2)_GFP_FOXI1|(07)_Ionocytes / shred by cell type by condition | 1.05e-05 | 172 | 128 | 6 | 5776b638b845d054f6e884e7df0412477f48517d | |
| ToppCell | wk_20-22-Epithelial-Proximal_epithelial-Proximal_secretory_2|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 1.09e-05 | 173 | 128 | 6 | d1e47c87bd4750801f3531f66a56c5dccb4ea64c | |
| ToppCell | 356C-Fibroblasts-Fibroblast-G|356C / Donor, Lineage, Cell class and subclass (all cells) | 1.24e-05 | 177 | 128 | 6 | 8220cc2fc0ee8764a67a3be51d75248be2453040 | |
| ToppCell | 356C-Fibroblasts-Fibroblast-G-|356C / Donor, Lineage, Cell class and subclass (all cells) | 1.24e-05 | 177 | 128 | 6 | 7617270f49cd6b7ba66db72d20560cee985012b2 | |
| ToppCell | droplet-Heart-4Chambers-21m-Neuronal-cardiac_neuron|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.28e-05 | 178 | 128 | 6 | 3e8aacb27ed1a3c3978e21dddddd0828f8000692 | |
| ToppCell | metastatic_Brain-Fibroblasts-Myofibroblasts|metastatic_Brain / Location, Cell class and cell subclass | 1.41e-05 | 181 | 128 | 6 | bd0b5f74f9c81ec0f1592710774a4fdf33d9d5a9 | |
| ToppCell | 5'-Adult-LymphNode-Mesenchymal-fibroblastic-Transitional_Stromal_3_(C3+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.41e-05 | 181 | 128 | 6 | ab66a89f316b935d9ba1277426d976b1e9e39757 | |
| ToppCell | Parenchymal-10x5prime-Epithelial-Epi_submucosal-gland-SMG_Duct|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.52e-05 | 108 | 128 | 5 | 9c7f3e25facfb54ef0be45044999bc36438bbea0 | |
| ToppCell | Parenchymal-10x5prime-Epithelial-Epi_submucosal-gland|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.52e-05 | 108 | 128 | 5 | 75d635fc5bb004418db2e1328c24d96b718f10b1 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.55e-05 | 184 | 128 | 6 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.55e-05 | 184 | 128 | 6 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.55e-05 | 184 | 128 | 6 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | facs-Liver-Liver_non-hepato/SCs-18m-Lymphocytic-B_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.64e-05 | 186 | 128 | 6 | a8fcb440d88770f95678c5d28413fc4d847f42a8 | |
| ToppCell | facs-Liver-Liver_non-hepato/SCs-18m-Lymphocytic-B_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.64e-05 | 186 | 128 | 6 | 6b2d15e2756d4d4d68ad600e4a6c074edc3488f2 | |
| ToppCell | Fibroblasts-CD55+_Fibroblasts|Fibroblasts / Immune cells in Rheumatoid Arthritis Joint Synovial Tissues | 1.85e-05 | 190 | 128 | 6 | b4088128f5acf53f43244c9af9fe44e033f1a57a | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.85e-05 | 190 | 128 | 6 | 45df8fee00f8949937863159d7aa042e72748d9b | |
| ToppCell | LPS_only-Stromal_mesenchymal-Matrix_Fibroblast-Diff_MatrixFB|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.85e-05 | 190 | 128 | 6 | d60395739458d7f47a3350ade751fe3819500320 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.91e-05 | 191 | 128 | 6 | d0e9afe7b6334dd515d3e68892efdc76347a55e5 | |
| ToppCell | E18.5-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.91e-05 | 191 | 128 | 6 | 4b50fdd310701251e64e16cd2d07ce03dbfd3e3e | |
| ToppCell | E15.5-Mesenchymal-mesenchymal_fibroblast-mesenchymal_alveolar_niche_cell|E15.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.91e-05 | 191 | 128 | 6 | 053b3664f509baa107feaf90730f80ebf9ac8f14 | |
| ToppCell | ASK440-Mesenchymal|ASK440 / Donor, Lineage and Cell class of Lung cells from Dropseq | 1.91e-05 | 191 | 128 | 6 | f12959eebb4167e1aa03de05d7711a702c58b3c9 | |
| ToppCell | E18.5-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2-AF2_mature|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.91e-05 | 191 | 128 | 6 | 75d2197076a9dfc868e8baf95bd4c5e44f438e3e | |
| ToppCell | metastatic_Lymph_Node-Fibroblasts-Myofibroblasts|metastatic_Lymph_Node / Location, Cell class and cell subclass | 1.91e-05 | 191 | 128 | 6 | aa43b472bc8362f79ae63f09f1ca764718bbf22c | |
| ToppCell | ASK440-Mesenchymal-Fibroblast|ASK440 / Donor, Lineage and Cell class of Lung cells from Dropseq | 1.91e-05 | 191 | 128 | 6 | 387296b5377ef6839f0812e5b3529a10b5f7d530 | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Matrix_Fibroblast|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.97e-05 | 192 | 128 | 6 | f4fc2b0121f879bab2bee99dfb5ff2c3ca1c0e1b | |
| ToppCell | LPS_only-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.97e-05 | 192 | 128 | 6 | df1545670370fb1010c567cd059c2783eab315f7 | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.97e-05 | 192 | 128 | 6 | 4e47a02007f562f29ba5910df64d32a0167d0bd1 | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_adventitial_fibro_(10)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 2.03e-05 | 193 | 128 | 6 | adc9fc94f9ec686a417d08c0b8b7b7ab687afec0 | |
| ToppCell | Adult-Mesenchymal-matrix_fibroblast_1_cell-D231|Adult / Lineage, Cell type, age group and donor | 2.03e-05 | 193 | 128 | 6 | ef2f456c094e6e3c6ee81e0668c953cb8d0e1c0a | |
| ToppCell | Control-Stromal-Myofibroblast|Stromal / Disease state, Lineage and Cell class | 2.03e-05 | 193 | 128 | 6 | 5896242f713ae5fd1a4ebb63827f15d7279dced2 | |
| ToppCell | COVID-19-Heart-Fib_2|Heart / Disease (COVID-19 only), tissue and cell type | 2.09e-05 | 194 | 128 | 6 | d91c9f2ec47319051fc398320693fddbe8bbd4d6 | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.09e-05 | 194 | 128 | 6 | 60622bd2f75bfe4c37f721cb12f03dab33f2f58d | |
| ToppCell | droplet-Marrow-nan-3m-Myeloid-granulocytopoietic_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.09e-05 | 194 | 128 | 6 | 8ef0b71fef5b84cfd04973f891215333e7035d1d | |
| ToppCell | Control-Stromal-Myofibroblast|World / Disease state, Lineage and Cell class | 2.09e-05 | 194 | 128 | 6 | 3c2266772c5b56e8e02a461e5193e29588028ee9 | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.09e-05 | 194 | 128 | 6 | 89b706af2b25991fc2707eb24f49ba6ff3ae01f7 | |
| ToppCell | 5'-Adult-SmallIntestine-Epithelial-Tuft-related-BEST4+_epithelial|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.15e-05 | 195 | 128 | 6 | e87b11e3242fdbed2e7f383e6876ec375af32bd4 | |
| ToppCell | Adult-Mesenchymal-matrix_fibroblast_1_cell-D122|Adult / Lineage, Cell type, age group and donor | 2.15e-05 | 195 | 128 | 6 | aa0add081881d349099d12efca5cdee098038d4e | |
| ToppCell | 5'-Adult-LargeIntestine-Epithelial-goblet|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.21e-05 | 196 | 128 | 6 | 847b3377f463bfded046eec63cc1b547f3dc33c1 | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.21e-05 | 196 | 128 | 6 | 42e9828222a9663525d571633e8a454c30bfa7f8 | |
| ToppCell | droplet-Heart-HEART_(ALL_MINUS_AORTA)-30m-Endothelial-endocardial_endothelial_cells|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.21e-05 | 196 | 128 | 6 | dbf154b3d166ffd07be717dac8d8a3350ac63e16 | |
| ToppCell | metastatic_Lymph_Node-Fibroblasts|metastatic_Lymph_Node / Location, Cell class and cell subclass | 2.21e-05 | 196 | 128 | 6 | 275e153347caf94edc0c50021bbab49c8696fecb | |
| ToppCell | COVID-19-Fibroblasts-Intermediate_pathological_FB|COVID-19 / group, cell type (main and fine annotations) | 2.27e-05 | 197 | 128 | 6 | f1c8936986123a3151140c374fcd62d6705c530b | |
| ToppCell | 10x3'2.3-week_17-19-Endothelial-stroma-sinusoidal_EC|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 2.27e-05 | 197 | 128 | 6 | 4e58bbf3ecb30b4c8199adcc04d2eb134d90de56 | |
| ToppCell | COVID-19-Fibroblasts|COVID-19 / group, cell type (main and fine annotations) | 2.27e-05 | 197 | 128 | 6 | fb847f2277609c31fffcdf49517243ce0684facf | |
| ToppCell | IPF-Stromal-Myofibroblast|Stromal / Disease state, Lineage and Cell class | 2.27e-05 | 197 | 128 | 6 | f304d42fc4936fe20996e07c8dccc698a6e5e5ef | |
| ToppCell | Adult-Mesenchymal|Adult / Lineage, Cell type, age group and donor | 2.34e-05 | 198 | 128 | 6 | 26e55b409db2a1637c95fae7c54b0abea1ef550c | |
| ToppCell | COVID-19-lung-Fibroblast|lung / Disease (COVID-19 only), tissue and cell type | 2.34e-05 | 198 | 128 | 6 | df3de77216f5c5d6141ec44d01c56b942f611838 | |
| ToppCell | Biopsy_Control_(H.)-Mesenchymal-Myofibroblasts|Biopsy_Control_(H.) / Sample group, Lineage and Cell type | 2.41e-05 | 199 | 128 | 6 | 7a227c239afdaebcac84644d9b2653a5f1a4be71 | |
| ToppCell | wk_15-18-Mesenchymal-Fibroblast-Adventitial_fibro|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 2.41e-05 | 199 | 128 | 6 | 8de6d7b2067b22cb9b5f01aa56a3803aebc4406d | |
| ToppCell | (04)_Interm._basal>secr.-(2)_GFP_FOXI1|(04)_Interm._basal>secr. / shred by cell type by condition | 2.41e-05 | 199 | 128 | 6 | 53ca3861f9e00dab3f3fbefb0837857ee39ab084 | |
| ToppCell | distal-Endothelial-Vein-3|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 2.41e-05 | 199 | 128 | 6 | f9fc0482d7ab11f2165b30cce3564b4ff87d61a6 | |
| ToppCell | 10x3'2.3-week_17-19-Mesenchymal_fibro-stroma-arteriolar_fibroblast|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 2.41e-05 | 199 | 128 | 6 | 95d95e9b7bd3933188998ae94986213eb0f1e5ea | |
| ToppCell | ILEUM-inflamed-(8)_Fibroblast|inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 2.41e-05 | 199 | 128 | 6 | cb3c04b91c8e8080137823b11c76ca0a2adda52d | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW08-Neuronal-Intermediate|GW08 / Sample Type, Dataset, Time_group, and Cell type. | 2.47e-05 | 200 | 128 | 6 | 401d50fa394fa863fa7836344110ae5c7af3250a | |
| ToppCell | 390C-Fibroblasts-Fibroblast-H-|390C / Donor, Lineage, Cell class and subclass (all cells) | 2.47e-05 | 200 | 128 | 6 | ec7d6a08e34bcad5b3bbff56ebef96ae17e4cefd | |
| ToppCell | Tracheal-NucSeq-Stromal-Fibroblastic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.47e-05 | 200 | 128 | 6 | b4ccffdd79526c85e5273d27b668dbddcddba1ee | |
| ToppCell | 10x3'2.3-week_12-13-Mesenchymal_fibro-stroma|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 2.47e-05 | 200 | 128 | 6 | 64d2941689d7ca8af54f9ba21c5aeabf719084ef | |
| ToppCell | Lung_Parenchyma-Severe-Mesenchymal|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 2.47e-05 | 200 | 128 | 6 | 6ce8e2cf689523993d909a27daec3d6a5824d13c | |
| ToppCell | Lung_Parenchyma-Severe-Mesenchymal-Mesenchymal|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 2.47e-05 | 200 | 128 | 6 | 907427e85cebe5a18c8a310e2ffa0e180ea3cb77 | |
| ToppCell | Bronchial-NucSeq-Stromal-Fibroblastic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.47e-05 | 200 | 128 | 6 | cae972324d1dfea6efeaf6013f265c7c6bb48db4 | |
| ToppCell | Parenchymal-NucSeq-Stromal-Fibroblastic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.47e-05 | 200 | 128 | 6 | 311fab076f2ceb258e3970eb21e39344b894042a | |
| ToppCell | 390C-Fibroblasts-Fibroblast-H|390C / Donor, Lineage, Cell class and subclass (all cells) | 2.47e-05 | 200 | 128 | 6 | 671e731977c58a0c44c36b56422085d93d999aad | |
| ToppCell | Parenchyma_COVID-19-Stromal-TX|Parenchyma_COVID-19 / Sample group, Lineage and Cell type | 2.47e-05 | 200 | 128 | 6 | 8472baa74c48b67c5f08223025885c833458290b | |
| Computational | Placenta genes. | VPS11 VWF CRIM1 DUSP4 GAS1 PTPRU ITGB4 SLC2A1 TMED3 MFAP4 FCGBP ALDH3B2 | 3.33e-05 | 463 | 69 | 12 | MODULE_38 |
| Drug | Menadione [58-27-5]; Down 200; 23.2uM; PC3; HT_HG-U133A | 6.35e-07 | 194 | 115 | 9 | 4662_DN | |
| Drug | Sanguinarine [2447-54-3]; Down 200; 12uM; MCF7; HT_HG-U133A | 5.82e-06 | 191 | 115 | 8 | 4168_DN | |
| Disease | Miller Dieker syndrome | 1.96e-04 | 29 | 115 | 3 | C0265219 | |
| Disease | Complement deficiency disease | 2.89e-04 | 33 | 115 | 3 | C0272242 | |
| Disease | Urogenital Abnormalities | 3.12e-04 | 7 | 115 | 2 | C0042063 | |
| Disease | beta-secretase 1 measurement | 4.15e-04 | 8 | 115 | 2 | EFO_0009179 | |
| Disease | Ataxias, Hereditary | 4.15e-04 | 8 | 115 | 2 | C0004138 | |
| Disease | Fanconi anemia (implicated_via_orthology) | 4.15e-04 | 8 | 115 | 2 | DOID:13636 (implicated_via_orthology) | |
| Disease | hepatocyte growth factor measurement | 6.80e-04 | 44 | 115 | 3 | EFO_0006903 | |
| Disease | ocular hypertension, response to triamcinolone acetonide | 9.32e-04 | 49 | 115 | 3 | EFO_0006954, EFO_1001069 | |
| Disease | Herpes Zoster, response to tofacitinib | 9.69e-04 | 12 | 115 | 2 | EFO_0006510, EFO_0600024 | |
| Disease | refractive error, age at onset, Myopia | 9.75e-04 | 193 | 115 | 5 | EFO_0004847, HP_0000545, MONDO_0004892 | |
| Disease | Fanconi anemia | 1.33e-03 | 14 | 115 | 2 | cv:C0015625 | |
| Disease | Intellectual Disability | 1.88e-03 | 447 | 115 | 7 | C3714756 | |
| Disease | ovarian neoplasm | 1.90e-03 | 134 | 115 | 4 | C0919267 | |
| Disease | Malignant neoplasm of ovary | 2.06e-03 | 137 | 115 | 4 | C1140680 | |
| Disease | C-C motif chemokine 3 measurement | 2.21e-03 | 18 | 115 | 2 | EFO_0008051 | |
| Disease | Bone marrow hypocellularity | 2.21e-03 | 18 | 115 | 2 | C1855710 | |
| Disease | MYELODYSPLASTIC SYNDROME | 2.30e-03 | 67 | 115 | 3 | C3463824 | |
| Disease | anorectal malformation | 2.47e-03 | 19 | 115 | 2 | MONDO_0019938 | |
| Disease | CCL4 measurement | 2.73e-03 | 20 | 115 | 2 | EFO_0004751 | |
| Disease | coagulation factor measurement | 2.73e-03 | 20 | 115 | 2 | EFO_0004634 | |
| Disease | gestational age, birth measurement | 3.01e-03 | 21 | 115 | 2 | EFO_0005112, EFO_0006921 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| VFYYEILNNPELACT | 176 | P27348 | |
| CYPCGNYVIFINIET | 41 | Q8NDM7 | |
| YANGCFEFDVYFPQD | 4621 | Q9NR09 | |
| VFYYEIQNAPEQACL | 181 | Q04917 | |
| YFNAGQTCVAPDYVL | 156 | P48448 | |
| EYQGCQAAEDLLQGY | 86 | Q7L5Y6 | |
| PKGYGFCEYQDQETA | 56 | P33240 | |
| QQFDLEPSEGCFYDY | 61 | P00736 | |
| ADEGPNAIVYYFIAA | 2756 | Q9H251 | |
| ASPEDVEYYNCQQEL | 366 | O14646 | |
| FEYQVCNSEECPGTY | 596 | Q8WXS8 | |
| YCNGEAIPIYAEIEN | 206 | Q8NCT1 | |
| NYYDVGARVPTAENC | 1226 | Q9HC84 | |
| SSLEPEDFAVYYCQQ | 96 | A0A0A0MRZ8 | |
| CNYYLQPEEDVTIGV | 126 | Q8N2K0 | |
| NYGVVDPDDLYDVYC | 236 | Q96GW7 | |
| YDEEIGYCQGQSFLA | 641 | Q9Y3P9 | |
| FPYNQCSYEGRFEDD | 171 | Q6ZTZ1 | |
| VPGYQGVNCEYEVDE | 1176 | Q04721 | |
| AQCFQQFPEGLFYEE | 101 | P0CW19 | |
| AQCFQQFPEGLFYEE | 101 | P0CW20 | |
| AYDVVCEDYGGDVQA | 306 | P46199 | |
| QYAQCTLEGAYEPGA | 81 | Q9GZZ0 | |
| CFQYVEQLCGPYVFI | 421 | P11166 | |
| SLQPEDFAVYYCQQD | 101 | A0A0C4DH55 | |
| YDGNLQCASPEYAQG | 336 | Q86UE6 | |
| GCEYQQCPSEFDYNA | 501 | O75487 | |
| YGEPESFGDNLYVCI | 426 | Q14526 | |
| EYREIVENNPAYLYC | 2766 | Q8NDA2 | |
| PAYYCNECDVEVFNI | 1571 | O15054 | |
| QNYFPVGTVVEYECR | 116 | P08174 | |
| CVPAELADYNNVIYA | 951 | Q86SJ6 | |
| VPANYADGVYQALEE | 61 | Q9NRD8 | |
| NEFAGVNEVDYCLYP | 286 | Q9NVF9 | |
| CVLNDTYYAPGEEVY | 4336 | Q02817 | |
| YLEEPYQNVCFQAFL | 201 | Q6AI08 | |
| IGRQCNEVEPGYYFA | 536 | P07942 | |
| QGEPECSYAYNQYAE | 56 | P54826 | |
| EGAVAYDPAANECYC | 326 | Q2TBA0 | |
| IGELDQNYFTCYAPV | 341 | Q9HCJ2 | |
| YEGQFCEYDNFQCPR | 531 | P16144 | |
| LDAYEDQYNQPGVVF | 346 | P09884 | |
| LSGVQPEDEAEYYCL | 96 | P04211 | |
| YDNGEYICVAVNEAG | 1331 | Q96RW7 | |
| AVPCEYSQAQYDDFQ | 36 | Q92729 | |
| GQAECYYFANASEPE | 156 | Q9H999 | |
| DADIIFCPYNYLLDA | 361 | Q9BX63 | |
| ALDVYNGEQAPYASC | 296 | P11117 | |
| FDYQLYFQEPGVAEA | 381 | P34913 | |
| ICFPEYKGQNTYEEA | 286 | P19086 | |
| VPQEDDYGYQCLEGK | 396 | Q8N1C3 | |
| AYNEELHYVEPCLNG | 296 | Q8IZS8 | |
| GVYYEPEQTVLIDNC | 1591 | Q9Y6R7 | |
| GAEAELQANPFYDRY | 66 | Q5TC12 | |
| DPVAFEYLYVQSCND | 301 | Q14CM0 | |
| PNYLNGFECFVCDYE | 381 | Q495W5 | |
| NYAADKGAPYVDVIC | 486 | P08236 | |
| ASYAEPGDCYEEIFQ | 426 | Q9P0X4 | |
| PGDCYEEIFQYVCHI | 431 | Q9P0X4 | |
| DTKPACVFNNVEYYD | 331 | Q9NZV1 | |
| GFLADQLDPIYVAYN | 1541 | Q9Y2E4 | |
| DYCFDYNPPDENQIV | 456 | Q8IXK2 | |
| FNQLCLPTYDSYEEV | 791 | O15033 | |
| FCDYGKAPGAEEYAQ | 256 | P09543 | |
| EYGHNEVVEYDCNPN | 226 | Q9BXR6 | |
| NQTDSELYAFECPVY | 3446 | Q0VDD8 | |
| YNYGNEDQAEFLCVV | 191 | Q9NXV2 | |
| DGSCNLASVEYYNPV | 546 | Q9UH77 | |
| SSLEPEDFAVYYCQQ | 96 | P04433 | |
| PEDFAVYYCQQDYNL | 101 | A0A075B6H7 | |
| VYDEDFEYGSQLPEC | 196 | Q9NYL5 | |
| PKGYGFCEYQDQETA | 56 | Q9H0L4 | |
| GFLADQLDPIYVAYN | 1556 | Q14689 | |
| ANQFEGNDRYEGYCV | 426 | P42261 | |
| AAYYIDCIRQVQPEG | 2286 | P49327 | |
| QVESAQFPEYDDLYC | 16 | Q9UPM9 | |
| FEGHYQYKCIPVEDN | 236 | Q13115 | |
| APVFIQDAGNYTCYA | 541 | Q7Z5N4 | |
| EDCYVFAQEYAPAGD | 121 | Q52WX2 | |
| LLGAQPEDEAEYYCL | 96 | A0A075B6I9 | |
| NHDQYPLEECYAVFI | 41 | Q96HA8 | |
| QELKEIFGENCYPDY | 41 | A0A1W2PPM1 | |
| LPYCGPNQVDYFICD | 171 | Q8NGC3 | |
| DCFPENYVPTVFENY | 46 | P61587 | |
| NCAVEFNFGQRAEPY | 376 | Q9BUJ2 | |
| PAAEDNYGYDACAVL | 301 | Q99567 | |
| NYQNVEYCGELKGDP | 746 | P22897 | |
| FVDDVNNNYYEAPSC | 976 | Q7Z2Y5 | |
| EDFLCDFGYYRPEND | 671 | Q99523 | |
| VNCVLAFQGYYLPND | 81 | Q86VP1 | |
| YAYQLDGTIPDQVCD | 311 | Q9NW38 | |
| IPNQLYYEGELQACA | 741 | Q9HCE1 | |
| EIYQYLGEPETFLFC | 201 | O60502 | |
| KEFPCVDGYIYDQNT | 121 | Q86VW1 | |
| EVDIIPQFSECQYDY | 306 | Q5K651 | |
| PNCIYDAVVIYGDSE | 471 | Q7RTY7 | |
| QQPLDCDDIYAQGYQ | 36 | P55083 | |
| NGDQYCGDYELFVEA | 66 | Q9H299 | |
| VVVDALPYFDQGYEA | 11 | O75934 | |
| AYEEYNPEVGYCRDL | 176 | B9A6J9 | |
| NRLYGEQEFPICQEY | 116 | Q96P63 | |
| ACDIVEDAAIAYGYN | 361 | Q9NSD9 | |
| GQVYCQPEFLYEGLE | 391 | Q9HAY6 | |
| AYEEYNPEVGYCRDL | 176 | A6NDS4 | |
| AYEEYNPEVGYCRDL | 176 | P0C7X1 | |
| QFIVAGDECVYLYQP | 246 | Q9H270 | |
| QCPCYYDGEIFQPED | 706 | P04275 | |
| AYEEYNPEVGYCRDL | 176 | A6NER0 | |
| INECYDGSYAGNPQD | 491 | Q15022 | |
| GHYDVDCYVEDPQGN | 61 | Q9Y3Q3 | |
| DCYVEDPQGNTIYRE | 66 | Q9Y3Q3 | |
| LILVNEPYYNEAGFD | 1071 | Q9C0C9 | |
| ENPEEPYLDGINYNC | 1101 | Q14683 | |
| AYEEYNPEVGYCRDL | 176 | A0A087X179 | |
| YYFPVKNVIDGDLCE | 1166 | Q15393 | |
| VYEVLFYNETEDCPG | 2321 | Q7Z7G8 | |
| DVAFYPNYEDCQTVE | 131 | Q96Q05 | |
| AYEEYNPEVGYCRDL | 176 | A0A087WVF3 | |
| NTVVNYCGPFEYEVG | 136 | Q8NHP8 | |
| DDVFNERDNCPYVYN | 806 | P35442 | |
| DIYSQPFGENADYPC | 821 | Q9BXT5 | |
| YYFVEVQAPADCVSA | 831 | Q15029 | |
| AYEEYNPEVGYCRDL | 176 | Q6DHY5 | |
| AYEEYNPEVGYCRDL | 176 | Q8IZP1 | |
| LDYNYPLCAVQAFGI | 416 | O75386 | |
| QGVVNFPYDDFIQCV | 181 | P30626 | |
| AYEEYNPEVGYCRDL | 176 | A0A087X1G2 | |
| VFCIYFQSGNNEEPY | 86 | P51811 | |
| AYEEYNPEVGYCRDL | 176 | A0A087WXS9 | |
| AYEEYNPEVGYCRDL | 176 | Q6IPX1 |